Skip to content

Fitness Integrative Training for Pediatric Rheumatology Disorders

Fitness Integrative Training for Pediatric Rheumatology Disorders (FIT Teens II): a Pilot Feasibility Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06556992
Acronym
FIT Teens 2
Enrollment
10
Registered
2024-08-16
Start date
2024-09-24
Completion date
2025-07-02
Last updated
2025-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Joint Hypermobility, Juvenile Dermatomyositis, Juvenile Idiopathic Arthritis, Systemic Lupus Erythematosus of Childhood

Brief summary

This study evaluates the feasibility of the Fitness Integrative Training program for Teens (FIT Teens 2), a combined cognitive behavioral therapy and neuromuscular exercise training program in patients with pediatric rheumatic diseases and/or joint hypermobility.

Interventions

BEHAVIORALFIT Teens

This intervention will consist of 16 in-person and remote group-based sessions held twice per week over 8 weeks. Sessions last 90 minutes and will be led jointly by a psychologist/therapist and exercise trainer using manualized protocols.

Sponsors

Children's Hospital Medical Center, Cincinnati
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Single arm behavioral intervention feasibility trial

Eligibility

Sex/Gender
ALL
Age
10 Years to 19 Years
Healthy volunteers
No

Inclusion criteria

* Pediatric rheumatic diseases (PRD) or joint hypermobility (JH) diagnosed by a pediatric rheumatologist or pain physician. * Initial diagnosis ≥ 3 months ago * Ages 10-19 years, inclusive * Ongoing symptoms of musculoskeletal pain and/or fatigue for at least 3 months * Functional Disability Index (FDI) Score ≥ 13 indicating at least moderate disability. * Child has written and spoken proficiency in English and parent has written and spoken proficiency in English or Spanish (will have a certified bilingual provider or interpreter available)

Exclusion criteria

* Untreated major psychiatric diagnoses (e.g., major depression, bipolar disorder, psychoses) or documented developmental delay. * Any other medical condition determined by their physician to be a contraindication for exercise. * Childhood Myositis Assessment Scale (CMAS) ≤ 30

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of Enrollment2 yearsMaintain consistent monthly enrollment for the duration of the project
Session Attendance8 weeksEvaluation of the number of sessions attended out of the 16 sessions offered
Participant Retention at Post-Treatment8 weeksNumber of participants completing post-treatment visit
Treatment Fidelity2 yearsAll sessions will be video-recorded and trainers adherence to the protocol will be assessed using an 9-item fidelity checklist (e.g., homework and diary review, CBT skill instruction and practice, neuromuscular exercise instruction and practice, CBT and exercise homework planning).
Participant Safety2 yearsAssessment of frequency and severity of adverse events possibly, likely, or definitely related to the study treatment or procedures

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026